companydata.dkLEO PHARMA A/S: Financial statements 2016
CVR: 56759514
LEO PHARMA A/S (CVR 56759514) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 7,360,000,000 and a net result of DKK 743,000,000 compared with DKK 645,000,000 the year before. That is an increase of 7% compared with the year before. The profit margin was 10.1%. Equity amounted to DKK 25,212,000,000. The solvency ratio was 66.6%. The company had 5,170 employees in the financial year.
- Revenue
- 7,360,000,000 kr.
- Gross Profit
- 2,716,000,000 kr.
- Profit/Loss
- 743,000,000 kr.
- Equity
- 25,212,000,000 kr.
- Total Assets
- 37,831,000,000 kr.
- Employees
- 5,170
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 7.4 mia. | 2.7 mia. | 743 mio. | 25.2 mia. | 5170 |
| 2015 | 6.9 mia. | 2 mia. | 645 mio. | 25.3 mia. | 4813 |
| 2014 | 6.6 mia. | - | 1.5 mia. | 24.5 mia. | 4712 |
| 2013 | 5.8 mia. | - | 1.2 mia. | 23.1 mia. | 4733 |
How creditworthy is LEO PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
As of December 9, 2016, Jan Rasmussen has joined the board of directors of LEO PHARMA A/S.
As of December 9, 2016, Morten Drewes Pedersen has left the board of directors of LEO PHARMA A/S.
As of June 24, 2016, Jesper Høiland has joined the board of directors of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2015. Revenue came to DKK 6,876,000,000, and the net result was DKK 645,000,000.
As of January 1, 2016, Jukka Pekka Pertola has joined the board of directors of LEO PHARMA A/S.
As of January 1, 2016, Patrik Olof Dahlén has joined the board of directors of LEO PHARMA A/S.
As of January 1, 2016, Poul Rødbroe Rasmussen has left the board of directors of LEO PHARMA A/S.
About LEO PHARMA A/S
LEO PHARMA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1962. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB. The management consists of Philip Harald Eickhoff and Christophe Dominique Luc Charles Bourdon. The company is owned by LEO Holding A/S and Cidron Savanna 4 SARL. The company has 2,040 employees. In 2025, the company reported revenue of DKK 13,499,000,000 and a net result of DKK 2,489,000,000 compared with DKK -1,776,000,000 the year before. Equity amounted to DKK 5,262,000,000.